| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |